Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Her passion for neuropharmacology drives her exploration of various vitamins, nootropics, and dietary supplements
[11] In April 2026 the sponsor announced that SYNCHRONIZE-1 a double-blind, placebo-controlled study of roughly 725 adults with obesity or overweight without diabetes met its co-primary endpoints, reporting mean bodyweight loss of about 16.6% at 76 weeks versus about 3.2% on placebo, with a large proportion of participants achieving at least 5% weight loss
Mol Pharm 13(7):23182331
Product Specifications Peptide: BPC-157 + TB-500 Dosage: 20mg total blend Form: Lyophilized powder Purity: 99% (HPLC verified) Use: Research use only Important Notice This product is intended strictly for laboratory and research purposes
The 2017 classification introduced stricter criteria for hypermobile EDS than previously available to distinguish patients with hypermobile EDS from those most likely to have a diagnosable genetic syndrome
US$ 27.27
US$ 22.57
US$ 28.44
